Editorially independent36 providers reviewedUpdated monthlyAffiliate-supported, never sponsoredEditorially independent36 providers reviewedUpdated monthlyAffiliate-supported, never sponsoredEditorially independent36 providers reviewedUpdated monthlyAffiliate-supported, never sponsoredEditorially independent36 providers reviewedUpdated monthlyAffiliate-supported, never sponsoredEditorially independent36 providers reviewedUpdated monthlyAffiliate-supported, never sponsoredEditorially independent36 providers reviewedUpdated monthlyAffiliate-supported, never sponsoredEditorially independent36 providers reviewedUpdated monthlyAffiliate-supported, never sponsoredEditorially independent36 providers reviewedUpdated monthlyAffiliate-supported, never sponsored

FDA-approved · 2021

Wegovy

Generic: Semaglutide · Manufactured by Novo Nordisk

FDA-approved specifically for chronic weight management. Higher dose of semaglutide than Ozempic. Oral version launched January 2026.

Avg weight loss

15-17% of body weight

Monthly price

$1,349

With insurance

$25-$200/month typical copay

Approved

2021

How it works

Mechanism
GLP-1 receptor agonist
Administration
Weekly subcutaneous injection or daily oral pill
Doses
0.25mg to 2.4mg (weekly injection), oral pill available
Approved for
Chronic weight management, Cardiovascular risk reduction
Self-pay options
Oral pill: $149/month at lowest dose (launched Jan 2026)
Oral version
Yes

Where to get Wegovy online

The 5 top-rated providers we’ve reviewed that prescribe Semaglutide.

See all 36 providers